142 related articles for article (PubMed ID: 22984631)
1. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
Zhai G; Yan K; Ji X; Xu W; Yang J; Xiong F; Su J; McNutt MA; Yang H
PLoS One; 2012; 7(9):e45290. PubMed ID: 22984631
[TBL] [Abstract][Full Text] [Related]
2. LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.
Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
PLoS One; 2012; 7(4):e34984. PubMed ID: 22509374
[TBL] [Abstract][Full Text] [Related]
3. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
[TBL] [Abstract][Full Text] [Related]
4. Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients.
Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
Med Oncol; 2012 Dec; 29(4):2809-13. PubMed ID: 22302286
[TBL] [Abstract][Full Text] [Related]
5. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
6. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.
Xu Y; Liu Y; Zhou R; Meng F; Gao Y; Yang S; Li X; Yang M; Lou G
Jpn J Clin Oncol; 2012 May; 42(5):413-9. PubMed ID: 22412199
[TBL] [Abstract][Full Text] [Related]
7. Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients.
Yang H; Lin M; Xiong F; Yang Y; Nie X; McNutt MA; Zhou R
Surg Today; 2011 Jun; 41(6):810-7. PubMed ID: 21626328
[TBL] [Abstract][Full Text] [Related]
8. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
9. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.
Li X; Kong X; Chen X; Zhang N; Jiang L; Ma T; Yang Q
PLoS One; 2012; 7(9):e44916. PubMed ID: 22984585
[TBL] [Abstract][Full Text] [Related]
10. LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.
Meng F; Li H; Zhou R; Luo C; Hu Y; Lou G
Biomarkers; 2013 Mar; 18(2):136-43. PubMed ID: 23312008
[TBL] [Abstract][Full Text] [Related]
11. Expression of LAPTM4B in gallbladder carcinoma cells: the role in invasive potential.
Zhou L; He XD; Yu JC; Zhou RL; Xiong FX; Qu Q; Rui JA
Hepatogastroenterology; 2010; 57(98):207-11. PubMed ID: 20583413
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
[TBL] [Abstract][Full Text] [Related]
13. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.
Wang B; Wang S; Liang G; Xu J; Zhou R; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317705518. PubMed ID: 28618967
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.
Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R
PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860
[TBL] [Abstract][Full Text] [Related]
15. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
Wang L; Meng Y; Zhang QY
BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma.
Zhou L; He XD; Chen J; Cui QC; Qu Q; Rui JA; Zhao YP
Eur J Cancer; 2007 Mar; 43(4):809-15. PubMed ID: 17276673
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer.
Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M
Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841
[TBL] [Abstract][Full Text] [Related]
18. Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients.
Zhai G; Yang H; Ji X; Xiong F; Su J; McNutt MA; Li X
Med Oncol; 2012 Dec; 29(4):2744-9. PubMed ID: 22207410
[TBL] [Abstract][Full Text] [Related]
19. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.
Qiao M; Hu G
Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706
[TBL] [Abstract][Full Text] [Related]
20. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
